Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely tenecteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
rekombinant koagulationsfaktor VIIa 60 000 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
rasburikas 1,5 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
tenekteplas 8 000 IE (40 mg), pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 1,6 milligram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Leuprorelin acetate 3.75 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely tenoxicam 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerande hormon alfa 37,5 IE, pulver till injektionsvätska, lösning, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely etanercept 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
terlipressin 1 mg, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
faktor VIII 1 000 IE + von Willebrand-faktor 2 200 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
rekombinant koagulationsfaktor IX 500 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
alprostadil 40 mikrogram, pulver till injektionsvätska, lösning, cylinderampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
immunglobulin anti-D (Rh) 1 500 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Alprostadil 40 microgram powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely sermorelin (as sermorelin acetate) 50 microgram/1 ampule powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Coagulation factor XIII 1250 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
rekombinant koagulationsfaktor VIIa 240 000 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
urofollitropin 150 enheter, pulver till injektionsvätska, lösning, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Rifampicin 600 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Alprostadil 5 microgram powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely coagulation factor XIII 250 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Alteplase 10 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely zoledronic acid 4 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely reteplase 10 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 24 milligram/patron, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
immunglobulin anti-D (Rh) 5 000 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely gonadorelin (as gonadorelin hydrochloride) 100 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Basiliximab 10 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
rekombinant koagulationsfaktor IX 1 000 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
immunglobulin anti-D (Rh) 600 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely sodium fusidate 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Sodium valproate 400 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
peginterferon alfa-2b 120 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
antihemofilifaktorpreparat 1 000 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Basiliximab 20 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 200 mikrogram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
antihemofilifaktorpreparat 1 500 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 400 mikrogram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
antihemofilifaktorpreparat 500 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cetrorelix (as cetrorelix acetate) 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 600 mikrogram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely vecuronium bromide 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 4 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
koriongonadotropin alfa 10 000 IE, pulver till injektionsvätska, lösning, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Interferon alfa-2b 1 million unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 6 milligram/patron, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Human alpha1 proteinase inhibitor 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
koriongonadotropin alfa 1 500 IE, pulver till injektionsvätska, lösning, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 800 mikrogram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
humant alfa-1-antitrypsin 500 mg, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
koriongonadotropin alfa 2 000 IE, pulver till injektionsvätska, lösning, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 1,2 milligram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
rekombinant koagulationsfaktor VIIa 120 000 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
koriongonadotropin alfa 5 000 IE, pulver till injektionsvätska, lösning, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Ixabepilone 15 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely disodium pamidronate 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 3 IE (1 mg), pulver till injektionsvätska, lösning, förfylld spruta |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 1,4 milligram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Leuprorelin acetate 11.25 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Disodium pamidronate 90 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Deferoxamine mesilate 2 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 1,3 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
rekombinant koagulationsfaktor IX 250 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
naltrexonmikrosfärer 380 mg, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Deferoxamine mesilate 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely omeprazole (as omeprazole sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Alprostadil 20 microgram powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 1,8 milligram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin 1,5 mg, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
hydroxokobalamin 2,5 g, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 2 milligram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
urofollitropin 75 IE, pulver till injektionsvätska, lösning, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 5,8 mg, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
torkad faktor IX-fraktion, upphettad, 600 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Palivizumab 50 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
lenograstim 263 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
abobotulinumtoxin A 500 enheter/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
faktor IX 500 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
faktor IX 1 000 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
somatropin (rbe) 16 IE (5,33 mg), pulver för beredning av injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Aciclovir (as aciclovir sodium) 250 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Amphotericin B 50 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Aciclovir (as aciclovir sodium) 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely clarithromycin 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Amifostine 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Amifostine 375 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|